US 8710223
Protein kinase C inhibitors and uses thereof
granted A61KA61K31/506A61P
Quick answer
US patent 8710223 (Protein kinase C inhibitors and uses thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/506, A61P, A61P1/00, A61P1/04